Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Abeona Therapeuticsabeonatherapeutics.com · Low evidenceAbeona Therapeutics Inc. is a commercial stage biopharmaceutical company developing cell and gene therapies for serious diseases, with its product ZEVASKYN® approved for recessive dystrophic epidermolysis bullosa. The company's pipeline includes PSMA SIR T™, an engineered T cell therapy targeting prostate cancer, and is supported by its own cGMP manufacturing facility in Cleveland.
Parse Score